{"database": "lobbying", "table": "lobbying_activities", "rows": [[955099, "4cc586da-bc2c-41cc-bed8-dbc8307055d0", "Q2", "PARRY, ROMANI, DECONCINI & SYMMS", 30792, "WEDGEWOOD VILLAGE PHARMACY, INC.", 2010, "second_quarter", "PHA", "Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.   No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.\n\nH.R. 3018, To amend the Controlled Substances Act to address the use of intrathecal pumps.  Amends the Controlled Substances Act to revise the definition of \"dispense\" to include the delivery of a controlled substance through the use of an intrathecal pump by a practitioner acting in the usual course of professional practice.", "HOUSE OF REPRESENTATIVES,SENATE", 11250, null, 0, 0, "2010-07-15T15:53:07.367000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["955099"], "units": {}, "query_ms": 13.44060298288241, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}